Suppliers / hameln pharma

hameln pharma

Germany 74 employees Updated 9 July 2026

hameln pharma is a finished-dose manufacturer based in Germany. It appears in 502 regulatory filings across 14 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, MHRA (UK) and AIFA (IT). Its GMP standing is certified by ZLG (DE) and EMA.

0
active US DMFs
0
valid CEPs
4
registered plants
502
filings across 14 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Niedersachsen, Germany Not on file
Lower Saxony, Germany Not on file
Hameln, Germany Not on file
Hameln, Germany Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 164 3
MHRA (UK) 116 None
AIFA (IT) 77 None
MPA (SE) 35 None
DKMA (DK) 31 None
INFARMED (PT) 21 None
ZLG (DE) None 18

Comparing suppliers?

Choose your molecules and target markets. hameln pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates